<- Go Home

Integramed America Inc.

IntegraMed America, Inc., a specialty healthcare services company, provides products and services to patients and providers in the fertility and vein care segments of healthcare industry in the United States. It offers business and management services to fertility centers and vein clinics in the areas of finance, accounting, human resources, risk management, and legal and purchasing support; marketing and sales support; Internet marketing and Website support; access to integrated information systems; non-physician personnel; and access to capital for financing clinic operations and expansion, as well as physician recruiting and training, regional management, revenue cycle management, and new practice development services to the vein clinics. The company provides its business and management services to a network of 15 contracted fertility centers in its partner program; and a network of 45 vein clinics located in 14 states, which offers specialized treatment for patients suffering from vein diseases and other vein disorders. IntegraMed America, Inc. also offers its Attain IVF products to its 15 contracted fertility centers and 24 affiliate fertility centers in 34 states and the District of Columbia, which are designed for fertility patients to attain their goal of starting a family. The company was founded in 1985 and is headquartered in Purchase, New York. As of September 20, 2012, Integramed America Inc. was taken private. Integramed America Inc. operates as a subsidiary of Integramed Holding Corp. On May 20, 2020, Integramed America Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with IntegraMed Holding Corp.

Market Cap

$168.5M

Volume

34.8K

Cash and Equivalents

$56.7M

EBITDA

$17.8M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$34.6M

Profit Margin

12.03%

52 Week High

$14.13

52 Week Low

$6.70

Dividend

N/A

Price / Book Value

1.83

Price / Earnings

32.99

Price / Tangible Book Value

5.21

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$8.9M

Return on Equity

5.72%

Return on Assets

3.45

Cash and Short Term Investments

$56.7M

Debt

$9.1M

Equity

$92.0M

Revenue

$287.3M

Unlevered FCF

$5.1M

Sector

Health Care Providers and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches